Prophylactic trimethoprim- sulfamethoxazole (TMP-SMX) 160/800 mg three times a week was initiated in patients with recurrent respiratory infections, independent of CD4+ counts. The gene discussed is CD4; the disease is respiratory tract infectious disorder.